Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Neumora Therapeutics
Entity

Neumora Therapeutics

Tracked across 2 events · 62 articles · First seen Feb 06, 2025 · Last active Apr 06, 2025

Sentiment
-60
Attention
4
Events
2
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
4 -70
Business
Neumora Therapeutics Securities Class Action
Impact: Neumora Therapeutics is the defendant in a securities class action lawsuit, accused of making misleading statements in its IPO offering documents regarding its Phase Two Trials and the therapeutic candidate Navacaprant.
Feb 11, 2025 · 56 articles
2 -50
Business
Neumora Therapeutics IPO Class Action
Impact: Neumora Therapeutics is the defendant in a class action lawsuit alleging false and misleading statements in its IPO Offering Documents, which could lead to significant financial penalties and reputational damage.
Feb 07, 2025 · 6 articles
Relationships (2)
BlackThorn Therapeutics acquirer ↔ Neumora Therapeutics Neumora Therapeutics acquired BlackThorn Therapeutics in September 2020, integra
BlackThorn Therapeutics target ↔ Neumora Therapeutics BlackThorn Therapeutics was acquired by Neumora Therapeutics in September 2020,
NEWSDESK
Track Neumora Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.